Eight Roads launches $250M China Healthcare Fund

Eight Roads (London, U.K.) launched its $250 million China Healthcare Fund. The fund will invest in healthcare services, IT and digital health, medical technology and therapeutics, which will comprise 40% of the allocated funding. It is the firm's fifth fund in China.

Eight Roads' portfolio includes antibody company Adagene Inc. (Suzhou, China), oncology database company Medbanks Network Technology Co. Ltd. (Beijing, China), and diabetes play Hua Medicine Ltd. (Shanghai, China)...